Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05531565
PHASE2/PHASE3

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Sponsor: Biogen

View on ClinicalTrials.gov

Summary

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with cutaneous lupus erythematosus (CLE). The study will focus on participants who have either active subacute CLE or chronic CLE, or both. They may also have systemic lupus erythematosus (SLE). The participants did not respond to antimalarial therapy or had problems with the treatment that made it hard to continue. The main objective of the study is to learn about the effect litifilimab has on lowering the activity of the skin disease. Researchers will measure symptoms and signs of CLE over time using a variety of scoring tools. These include the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI), the Cutaneous Lupus Activity of Investigator's Global Assessment-Revised (CLA-IGA-R), and the SELENA-SLEDAI Flare Index (SFI). The main questions researchers want to answer are: * How many participants have a score of 0 or 1 on the CLA-IGA-R looking at skin redness after treatment? * How many participants have their skin disease activity go down by at least 70% as measured by CLASI? Researchers will also learn more about the safety of litifilimab. They will study how participants' immune systems respond to litifilimab. Additionally, they will measure the effect litifilimab and CLE have on the quality of life of participants using a group of questionnaires. The study will be split into 2 parts - Part A and Part B. Both parts will be done as follows: * After screening, participants will be randomized to receive either litifilimab or placebo for the 1st treatment period. A placebo looks like the study drug but contains no real medicine. * Participants will receive either litifilimab or placebo as injections under the skin once every 4 weeks. * The 1st treatment period will be double blinded which means neither the researchers nor the participants will know if the participants are receiving litifilimab or placebo. * This double blinded treatment period will last 24 weeks, after which the 2nd treatment period will begin. * During the 2nd treatment period, all participants will receive litifilimab for 28 weeks. * After completing treatment in this study, participants that qualify will be given the choice to join the Long-Term Extension study, 230LE305. If they do not, they will move into a follow-up safety period that will last up to 24 weeks. * The total study duration for participants will be up to 80 weeks.

Official title: A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

450

Start Date

2022-09-13

Completion Date

2027-12-14

Last Updated

2026-10-23

Healthy Volunteers

No

Interventions

DRUG

Litifilimab

Administered as specified in the treatment arm.

DRUG

Placebo

Administered as specified in the treatment arm.

Locations (315)

Pinnacle Research Group, LLC

Anniston, Alabama, United States

UAB Center for Women's Reproductive Health

Birmingham, Alabama, United States

Arizona Arthritis & Rheumatology Research, PLLC

Phoenix, Arizona, United States

The Regents of the University of California

La Jolla, California, United States

Dermatology Research Associates

Los Angeles, California, United States

Clinical Science Institute

Santa Monica, California, United States

Inland Rheumatology Clinical Trials, Inc.

Upland, California, United States

Denver Arthritis Clinic

Denver, Colorado, United States

Omega Research Debary, LLC

DeBary, Florida, United States

Centre for Rheumatology, Immunology and Arthritis

Fort Lauderdale, Florida, United States

University of Florida

Gainesville, Florida, United States

University of Miami Miller School of Medicine

Miami, Florida, United States

Millennium Medical Research, LLC

Miami, Florida, United States

Medical Research Center of Miami

Miami, Florida, United States

Diverse Clinical Research LLC

Miami, Florida, United States

Charisma Medical and Research Center

Miami Lakes, Florida, United States

Leading Edge Dermatology

Plantation, Florida, United States

Augusta University

Augusta, Georgia, United States

Rush University Medical Center

Chicago, Illinois, United States

OrthoIllinois

Rockford, Illinois, United States

Dawes Fretzin Clinical Research Group, LLC

Indianapolis, Indiana, United States

Equity Medical

Bowling Green, Kentucky, United States

LSU Health Sciences Center Shreveport

New Orleans, Louisiana, United States

Tufts Medical Center

Boston, Massachusetts, United States

Brigham And Women's Hospital

Boston, Massachusetts, United States

Essential Dermatology

Natick, Massachusetts, United States

Beacon Clinical Research, LLC

Quincy, Massachusetts, United States

University of Massachusetts, Worcester

Worcester, Massachusetts, United States

David Fivenson, MD, Dermatology, PLLC

Ann Arbor, Michigan, United States

Oakland Hills Dermatology

Auburn Hills, Michigan, United States

AA MRC LLC Ahmed Arif Medical Research Center

Flint, Michigan, United States

Revival Research Institute, LLC

Troy, Michigan, United States

Saint Louis University

St Louis, Missouri, United States

University of Nebraska Medical Center

Omaha, Nebraska, United States

Albuquerque Center For Rheumatology

Albuquerque, New Mexico, United States

University of New Mexico School of Medicine

Albuquerque, New Mexico, United States

NYU Langone Brooklyn

Brooklyn, New York, United States

Universal Dermatology, PLLC

Fairport, New York, United States

Northwell Health, Inc. PRIME

Great Neck, New York, United States

Columbia University Medical center

New York, New York, United States

Hawthorne Health

Staten Island, New York, United States

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

Duke Dermatology South Durham

Durham, North Carolina, United States

Medication Management, LLC

Greensboro, North Carolina, United States

University of Cincinnati Department of Dermatology

Cincinnati, Ohio, United States

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

Ohio State University

Columbus, Ohio, United States

Penn State University Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Austin Regional Clinic, P.A.

Austin, Texas, United States

Precision Comprehensive Clinical Research Solutions

Colleyville, Texas, United States

Metroplex Clinical Research Center, LLC

Dallas, Texas, United States

UT Southwestern Medical Center

Dallas, Texas, United States

North Texas Center for Clinical Research

Frisco, Texas, United States

UTMB Department of Dermatology

Galveston, Texas, United States

University of Texas Health Science Center at Houston

Houston, Texas, United States

Arthritis & Osteoporosis Clinic

Waco, Texas, United States

Velocity Clinical Research Waco

Waco, Texas, United States

University of Utah Health Sciences Center

Salt Lake City, Utah, United States

Open Door Clinical Research

Blacksburg, Virginia, United States

West End Dermatology Associates

Richmond, Virginia, United States

CINME - Centro De Investigaciones Metabolicas

CABA, Buenos Aires, Argentina

Centro de Investigaciones Medicas Mar del Plata

Mar del Plata, Buenos Aires, Argentina

Instituto de Investigaciones Clinicas Quilmes

Quilmes, Buenos Aires, Argentina

Centro de Investigaciones San Miguel

San Miguel, Buenos Aires, Argentina

APRILLUS Asistencia e Investigacion

Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina

Fundacion Respirar

Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina

Consultorio Alto Dorrego

Villa Nueva, Mendoza Province, Argentina

Instituto CAICI

Rosario, Santa Fe Province, Argentina

Clinica Mayo de Urgencias Medicas Cruz Blanca SRL

San Miguel de Tucumán, Tucumán Province, Argentina

Centro de Investigaciones Medicas Tucuman

San Miguel de Tucumán, Tucumán Province, Argentina

Investigaciones Clinicas Tucuman

San Miguel de Tucumán, Tucumán Province, Argentina

Hospital Italiano de La Plata

Buenos Aires, Argentina

Hospital Italiano de Buenos Aires

Ciudad Autonoma Buenos Aires, Argentina

Centro Privado de Medicina Familiar - Mind Out Research

Ciudad Autonoma Buenos Aires, Argentina

Clinica Adventista Belgrano

Ciudad Autonoma Buenos Aires, Argentina

Instituto de Reumatologia

Mendoza, Argentina

CER San Juan Centro Polivalente de Asistencia e Inv. Clinica

San Juan, Argentina

UZ Leuven

Leuven, Vlaams-Brabant, Belgium

Cliniques Universitaires Saint-Luc

Brussels, Belgium

Universitair Ziekenhuis Gent

Ghent, Belgium

Centre Hospitalier Universitaire de Liege

Liège, Belgium

Integrare Terapêutica

Fortaleza, Ceará, Brazil

HUWC - UFC - Hospital Universitário Walter Cantídio - Universidade Federal do Ceará

Fortaleza, Ceará, Brazil

CEDOES - Diagnóstico e Pesquisa

Vitória, Espírito Santo, Brazil

Clínica SER da Bahia

Salvador, Estado de Bahia, Brazil

L2IP - Instituto de Pesquisas Clínicas Ltda.

Brasília, Federal District, Brazil

IPC MT Instituto de Pesquisas Clinicas do Mato Grosso

Santo Ângelo, Mato Grosso, Brazil

Santa Casa de Misericordia de Belo Horizonte

Belo Horizonte, Minas Gerais, Brazil

Freire Pesquisa Clinica

Belo Horizonte, Minas Gerais, Brazil

Clinica Pulsus

Belo Horizonte, Minas Gerais, Brazil

CMiP - Centro Mineiro de Pesquisa

Juiz de Fora, Minas Gerais, Brazil

Instituto Brasil de Pesquisa Clínica-IBPCLIN S/A

Rio de Janeiro, Rio Do Janeiro, Brazil

IDERJ - Instituto de Dermatologia e Estética do Brasil Ltda

Rio de Janeiro, Rio Do Janeiro, Brazil

Hospital Bruno Born

Lajeado, Rio Grande do Sul, Brazil

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Nucleo de Pesquisa Clinica do Rio Grande do Sul

Porto Alegre, Rio Grande do Sul, Brazil

LMK Serviços Médicos S/S Ltda

Porto Alegre, Rio Grande do Sul, Brazil

Hospital Moinhos de Vento

Porto Alegre, Rio Grande do Sul, Brazil

And 215 more locations on ClinicalTrials.gov